home / stock / rgen / rgen news


RGEN News and Press, Repligen Corporation

Stock Information

Company Name: Repligen Corporation
Stock Symbol: RGEN
Market: NASDAQ
Website: repligen.com

Menu

Get RGEN Alerts

News, Short Squeeze, Breakout and More Instantly...

RGEN - Repligen Corporation (RGEN) Presents at Leerink Global Healthcare Conference 2026 Transcript

2026-03-10 14:20:15 ET Repligen Corporation (RGEN) Leerink Global Healthcare Conference 2026 March 10, 2026 11:20 AM EDT... Read the full article on Seeking Alpha For further details see: Repligen Corporation (RGEN) Presents at Leerink Global Healthcare Conference 2026 Trans...

RGEN - Brown Capital Dumps 190,000 AppFolio Shares Worth $45.1 Million

2026-03-06 16:52:30 ET On February 17, 2026, Brown Capital Management reported selling 189,819 AppFolio shares, an estimated $45.11 million trade based on quarterly average pricing, per SEC filings. According to a Securities and Exchange Commission (SEC) filing dated February 17, 20...

RGEN - Baron Health Care Fund adds TMO, ARQT, and ELAN; exits Cidara Therapeutics, MASI among Q4 moves

2026-03-06 08:28:08 ET More on Thermo Fisher Scientific, Arcutis Biotherapeutics, etc. Thermo Fisher Scientific Inc. (TMO) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript Elanco Animal Health Incorporated (ELAN) Presents at TD Cowen 46th An...

RGEN - Repligen Corporation to Present at Upcoming March Conferences

WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating in three upcoming investor conferences. The Leerink Global Healthcare Conference, being h...

RGEN - Baron Health Care Fund Q4 2025 Recent Activity

2026-03-03 10:36:00 ET ... Read the full article on Seeking Alpha For further details see: Baron Health Care Fund Q4 2025 Recent Activity

RGEN - Overweight Recommendation Issued On RGEN By KeyBanc

2026-02-25 09:15:07 ET KeyBanc analyst issues OVERWEIGHT recommendation for RGEN on February 25, 2026 01:32PM ET. The previous analyst recommendation was Overweight. RGEN was trading at $133.05 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

RGEN - Repligen outlines $810M-$840M 2026 revenue target while expanding analytics and protein franchises

2026-02-24 14:28:39 ET More on Repligen Repligen Corporation (RGEN) Q4 2025 Earnings Call Transcript Repligen Corporation (RGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Repligen Corporation (RGEN) Presents at Evercore 8th Annual Healthcar...

RGEN - Repligen Corporation (RGEN) Q4 2025 Earnings Call Transcript

2026-02-24 14:28:01 ET Repligen Corporation (RGEN) Q4 2025 Earnings Call February 24, 2026 8:30 AM EST Company Participants Jacob Johnson - Vice President of Investor Relations Olivier Loeillot - President, CEO & Director Jason Garland - CFO & Chief Complia...

RGEN - Repligen (RGEN) Q4 2025 Earnings Call Transcript

2026-02-24 10:26:04 ET Image source: The Motley Fool. Tuesday, Feb. 24, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

RGEN - Repligen beats top-line and bottom-line estimates; introduces FY26 outlook

2026-02-24 07:39:00 ET More on Repligen Repligen Corporation (RGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Repligen Corporation (RGEN) Presents at Evercore 8th Annual Healthcare Conference Transcript Repligen Q4 2025 Earnings Preview ...

Next 10